Hansoh Pharma (03692): NDA for Olesatide Injection Accepted by China's NMPA for Long-Term Weight Management
Jun 04, 2026 07:39
CST Updated
10:13
Hansoh Pharma
Pharmaceutical Research, Production, and Sales
Pharmaceutical Research, Production, and Sales